Jorge defines and executes the innovation agenda at Hospital Clínic Barcelona, a top public tertiary hospital, among the top 30 in the world according to the Newsweek Rankings. According to Newsweek's ranking of the World's Best Specialized Hospitals in 2024, Clínic Barcelona ranks #8 in Obstetrics & Gynecology, #19 in Urology, #34 in Cardiac Surgery, and #35 in Cardiology worldwide. Jorge coordinates the innovation agenda at all the institutions that compose Campus Clínic Barcelona: Hospital Clínic Barcelona (a top public tertiary hospital), IDIBAPS (the research foundation), ISGlobal (the global health research foundation) and Mon Clínic (the private not-for-profit foundation).

He also acts as Venture Partner at Nina Capital, a specialized venture capital firm investing exclusively in the intersection of healthcare and technology at the pre-seed and seed stages. As a venture partner, Jorge helps the firm identifying the right companies and then helping the founders of those portfolio companies with advice and connections.

Previously, Jorge was Director of Innovation (portfolio of over 140 large-scale projects) and member of the Executive Management Board of EIT Health (Munich, 2018-2022), an independent official body of the European Union, mandated to accelerate innovation and entrepreneurship in healthcare and life sciences in Europe. He has extensive knowledge of healthcare systems in Europe, both from the providers' side as well as corporates, startups and investors.

Jorge was Director of Digital Health at Hospital Sant Joan de Déu Barcelona (2010-2018) and Director of d·HEALTH Barcelona (2012-2018), a Stanford Biodesign program where interdisciplinary teams experience a full cycle of innovation, from need identification in clinical settings through invention to early-stage implementation.

Jorge is a founding member of the European Society for Artificial Intelligence in Health (ESIAH) and serves on its Executive Committee. He contributes to the Society’s establishment and early growth, supporting its mission to advance the responsible integration of AI into clinical practice, research, and health innovation.